These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21835143)

  • 1. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
    Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
    J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H; Zhang X; Su Y; Jia C; Dai C
    Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.
    Calderaro J; Nault JC; Balabaud C; Couchy G; Saint-Paul MC; Azoulay D; Mehdaoui D; Luciani A; Zafrani ES; Bioulac-Sage P; Zucman-Rossi J
    Mod Pathol; 2016 Jan; 29(1):43-50. PubMed ID: 26516697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.
    Pilati C; Amessou M; Bihl MP; Balabaud C; Nhieu JT; Paradis V; Nault JC; Izard T; Bioulac-Sage P; Couchy G; Poussin K; Zucman-Rossi J
    J Exp Med; 2011 Jul; 208(7):1359-66. PubMed ID: 21690253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
    Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
    Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
    JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
    Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Real-Time COLD- and MAMA-PCR TaqMan Techniques to Detect and Quantify R201 GNAS Mutations in the McCune-Albright Syndrome
.
    de Sanctis L; Galliano I; Montanari P; Matarazzo P; Tessaris D; Bergallo M
    Horm Res Paediatr; 2017; 87(5):342-349. PubMed ID: 28334704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.
    Gaujoux S; Pasmant E; Silve C; Mehsen-Cetre N; Coriat R; Rouquette A; Douset B; Prat F; Leroy K
    Medicine (Baltimore); 2019 Dec; 98(50):e18102. PubMed ID: 31852070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
    Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
    Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minireview: GNAS: normal and abnormal functions.
    Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
    Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing.
    Narumi S; Matsuo K; Ishii T; Tanahashi Y; Hasegawa T
    PLoS One; 2013; 8(3):e60525. PubMed ID: 23536913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS imprinting and pituitary tumors.
    Mantovani G; Lania AG; Spada A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome.
    Romanet P; Philibert P; Fina F; Cuny T; Roche C; Ouafik L; Paris F; Reynaud R; Barlier A
    J Pediatr; 2019 Feb; 205():281-285.e4. PubMed ID: 30442414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.